Volume 22, Number 6—June 2016
Dispatch
Changes in Childhood Pneumonia Hospitalizations by Race and Sex Associated with Pneumococcal Conjugate Vaccines
Table
Patient age, y, and race | Patient sex | Hospitalizations/1,000 children |
Post-PCV13 vs. pre-PCV7 |
|||
---|---|---|---|---|---|---|
Pre-PCV7, 1998–1999, 11,059 hospitalizations | Post-PCV13, 2011–2013, 9,171 hospitalizations | Rate ratio (95% CI) | Rate difference (95% CI)† | |||
All‡ |
4.0 |
2.0 |
0.51 (0.50–0.52) |
−2.0 (−2.1 to −1.9) |
||
<2‡ | 18.4 | 7.3 | 0.40 (0.38–0.41) | −11.1 (−11.6 to −10.6) | ||
Black | M | 27.1 | 8.5 | 0.31 (0.28–0.35) | −18.6 (−20.5 to −16.6) | |
Black | F | 20.0 | 6.4 | 0.32 (0.28–0.37) | −13.6 (−15.3 to −11.9) | |
White | M | 18.0 | 7.8 | 0.43 (0.40–0.46) | −10.2 (−11.1 to −9.3) | |
White |
F |
14.5 |
6.2 |
0.43 (0.40–0.47) |
−8.2 (−9.0 to −7.4) |
|
2–4‡ | 5.4 | 3.0 | 0.56 (0.52–0.59) | −2.4 (−2.6 to −2.1) | ||
Black | M | 6.6 | 3.4 | 0.50 (0.43–0.59) | −3.3 (−4.1 to −2.5) | |
Black | F | 5.3 | 3.1 | 0.58 (0.49–0.70) | −2.2 (−3.0 to −1.5) | |
White | M | 5.3 | 3.0 | 0.56 (0.51–0.62) | −2.3 (−2.7 to −1.9) | |
White |
F |
5.0 |
2.9 |
0.59 (0.53–0.65) |
−2.0 (−2.4 to −1.6) |
|
5–17‡ | 1.6 | 1.1 | 0.67 (0.63–0.70) | −0.5 (−0.6 to −0.5) | ||
Black | M | 2.0 | 1.1 | 0.57 (0.49–0.65) | −0.8 (−1.1 to −0.6) | |
Black | F | 1.6 | 1.0 | 0.61 (0.53–0.71) | −0.6 (−0.8 to −0.4) | |
White | M | 1.6 | 1.1 | 0.70 (0.65–0.75) | −0.5 (−0.6 to −0.4) | |
White | F | 1.6 | 1.2 | 0.74 (0.68–0.80) | −0.4 (−0.5 to −0.3) |
*PCV7, 7-valent pneumococcal conjugate vaccine; PCV13, 13-valent pneumococcal conjugate vaccine.
†For hospitalizations per 1,000 children.
‡Includes all race/ethnicity categories (black, white, Hispanic, other). These estimates were not different from estimates including only black and
white children.
Page created: August 18, 2016
Page updated: August 18, 2016
Page reviewed: August 18, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.